Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential Interferon alfa-2b in patients with advanced melanoma

Sofie Wilgenhof, An Van Nuffel, Daphné Benteyn, L. Pierret, Carlo Heirman, Arlette De Coninck, Ivan Van Riet, Aude Bonehill, Kris Thielemans, Bart Neyns

Research output: Contribution to journalOther scientific journal contribution

Original languageEnglish
JournalASCO Annual Meeting, Florida, USA
Publication statusPublished - May 2009


  • vaccination
  • TriMix
  • dendritic cells
  • interferon a-2b
  • melanoma

Cite this